Chemical | 01 March 2021
Orbia Q4FY20 net revenue up 6%
Orbia expects EBITDA to increase between 4 to 7%.
Orbia expects EBITDA to increase between 4 to 7%.
The Group’s performance improved in 2H2020 due to China’s rapidly recovering economy and the auto market’s rebound.
Overall core market conditions for all of the businesses are now positive, particularly in Asia.
The transaction is expected to close by the middle of 2021, subject to regulatory and third-party approvals.
ExxonMobil intends to use results from the Baytown trial to scale-up advanced recycling capabilities at other global facilities.
Bayer has announced a series of decisions to accelerate the strategy implementation of its Crop Science division.
The acquisition significantly strengthens and expands Grace’s existing pharma portfolio and the transaction is expected to close in the second quarter of 2021
The purpose of the study is to assess the technical and economic feasibility of installing carbon capture at its Norwegian plants in Bjølvefossen, Bremanger, Rana, Salten and Thamshavn
IVL is undergoing various transformative initiatives, on our journey towards establishing institutional excellence and efficiency.
These awards are a recognition of the company's commitment to deliver value and support the continued growth across their markets.
Initially 10% of the gas feed will be replaced by hydrogen.
Janus will chair the upcoming 2021 AGM, scheduled to take place on 24 June 2021.
The company accelerated its digital transformation and successfully expanded its presence in several parts of the world in 2020.
BASF aims to increase its sales to between €61 billion and €64 billion in 2021.
The tenure is for 7 years including 2 years moratorium period.
The project is expected to be commissioned by September 2024.
_256_384.jpg)
UOP will provide a range of technology licenses, engineering design, key equipment and state-of-the-art catalysts and adsorbents, operator training, and technical services for start-up and continuing operations
.jpg)
The company expects to generate an EBITDA margin before special items of around 27 percent in 2021.
The divestment of PMMA is expected to close in mid-year.
Building upon the momentum gained by pharma sector during the pandemic, Indian Pharmaceutical Alliance is leaving no stone unturned to create a faster road to recovery.
Subscribe to our newsletter & stay updated.
_195_291.jpg)
